[Report of 428 Pages] Pressure infusion cuff demand is anticipated to grow at a 6.3% CAGR between 2022 and 2032, surpassing a valuation of about US$ 311.7 Mn in 2022. By 2032, sales of pressure infusion cuffs are anticipated to be worth US$ 573.2 million. In terms of application, the blood & drug infusions segment c.
Former SMHS professor, cardiologist dies at 89 gwhatchet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gwhatchet.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced.
The study met secondary study endpoints and long-term sensor use was associated with significant improvements in patient quality-of-life metrics and low event rates for heart failure hospitalization